Peptron, Inc. (087010.KQ)
KRW 98300.0
(-1.99%)
KRW 98300.0
(-1.99%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 52.49 Billion KRW | -23.11% |
| 2022 | 68.27 Billion KRW | -12.32% |
| 2021 | 77.86 Billion KRW | -33.84% |
| 2020 | 117.7 Billion KRW | 93.0% |
| 2019 | 60.98 Billion KRW | -15.01% |
| 2018 | 71.75 Billion KRW | 35.27% |
| 2017 | 53.04 Billion KRW | -8.38% |
| 2016 | 57.9 Billion KRW | 167.36% |
| 2015 | 21.65 Billion KRW | 87.08% |
| 2014 | 11.57 Billion KRW | 73.3% |
| 2013 | 6.67 Billion KRW | -57.8% |
| 2012 | 15.83 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 49.9 Billion KRW | -4.93% |
| 2024 Q2 | 41.87 Billion KRW | -16.11% |
| 2023 Q3 | 54.85 Billion KRW | -7.15% |
| 2023 Q1 | 63.92 Billion KRW | -6.36% |
| 2023 Q2 | 59.07 Billion KRW | -7.59% |
| 2023 FY | 52.49 Billion KRW | -23.11% |
| 2023 Q4 | 52.49 Billion KRW | -4.3% |
| 2022 Q4 | 68.27 Billion KRW | -1.27% |
| 2022 Q3 | 69.15 Billion KRW | -4.98% |
| 2022 Q2 | 72.77 Billion KRW | -3.65% |
| 2022 FY | 68.27 Billion KRW | -12.32% |
| 2022 Q1 | 75.53 Billion KRW | -3.0% |
| 2021 Q4 | 77.86 Billion KRW | -2.55% |
| 2021 FY | 77.86 Billion KRW | -33.84% |
| 2021 Q2 | 111.33 Billion KRW | -1.11% |
| 2021 Q3 | 79.9 Billion KRW | -28.23% |
| 2021 Q1 | 112.57 Billion KRW | -4.35% |
| 2020 Q1 | 57.99 Billion KRW | -4.91% |
| 2020 Q4 | 117.7 Billion KRW | 113.04% |
| 2020 Q2 | 54 Billion KRW | -6.87% |
| 2020 Q3 | 55.24 Billion KRW | 2.29% |
| 2020 FY | 117.7 Billion KRW | 93.0% |
| 2019 Q3 | 61.6 Billion KRW | -5.5% |
| 2019 Q2 | 65.19 Billion KRW | -7.18% |
| 2019 Q1 | 70.23 Billion KRW | -2.13% |
| 2019 FY | 60.98 Billion KRW | -15.01% |
| 2019 Q4 | 60.98 Billion KRW | -1.01% |
| 2018 Q1 | 77.69 Billion KRW | 46.47% |
| 2018 FY | 71.75 Billion KRW | 35.27% |
| 2018 Q3 | 73.53 Billion KRW | -3.5% |
| 2018 Q2 | 76.19 Billion KRW | -1.93% |
| 2018 Q4 | 71.75 Billion KRW | -2.41% |
| 2017 Q3 | 54.65 Billion KRW | -1.56% |
| 2017 Q4 | 53.04 Billion KRW | -2.94% |
| 2017 FY | 53.04 Billion KRW | -8.38% |
| 2017 Q1 | 56.6 Billion KRW | -2.25% |
| 2017 Q2 | 55.52 Billion KRW | -1.9% |
| 2016 Q2 | 59.77 Billion KRW | 187.4% |
| 2016 Q1 | 20.79 Billion KRW | -3.96% |
| 2016 FY | 57.9 Billion KRW | 167.36% |
| 2016 Q4 | 57.9 Billion KRW | -2.01% |
| 2016 Q3 | 59.09 Billion KRW | -1.15% |
| 2015 Q4 | 21.65 Billion KRW | -2.92% |
| 2015 Q2 | 10.39 Billion KRW | -5.38% |
| 2015 Q1 | 10.98 Billion KRW | 0.0% |
| 2015 FY | 21.65 Billion KRW | 87.08% |
| 2015 Q3 | 22.3 Billion KRW | 114.61% |
| 2014 Q1 | - KRW | 0.0% |
| 2014 FY | 11.57 Billion KRW | 73.3% |
| 2013 FY | 6.67 Billion KRW | -57.8% |
| 2012 FY | 15.83 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | 93.017% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | 46.767% |
| BINEX Co., Ltd. | 257.01 Billion KRW | 79.574% |
| Bioneer Corporation | 315.48 Billion KRW | 83.36% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | 64.87% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | 88.318% |
| CrystalGenomics, Inc. | 243.11 Billion USD | 78.407% |
| Helixmith Co., Ltd | 227.27 Billion KRW | 76.902% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 96.958% |
| Medy-Tox Inc. | 611.62 Billion KRW | 91.417% |
| Amicogen, Inc. | 467.09 Billion KRW | 88.761% |
| Genexine, Inc. | 376.58 Billion KRW | 86.06% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | 73.856% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | 72.298% |
| ALTEOGEN Inc. | 256.09 Billion KRW | 79.502% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | 90.193% |
| SillaJen, Inc. | 76.71 Billion KRW | 31.57% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | 79.18% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | 48.946% |
| Genomictree Inc. | 132.84 Billion KRW | 60.483% |
| MedPacto, Inc. | 80.47 Billion KRW | 34.767% |
| D&D Pharmatech | 79.2 Billion KRW | 33.72% |
| EASY BIO,Inc. | 172.04 Billion KRW | 69.486% |
| GI Innovation, Inc. | 81.34 Billion KRW | 35.461% |